Inhibition of thrombin-induced neuronal cell death by recombinant thrombomodulin and E5510, a synthetic thrombin receptor signaling inhibitor

Thrombosis and Haemostasis

Volumn 82, Issue 3, 1999, Pages 1071-1077

  Sarker, Krishna Pada ^a   Abeyama, Kazuhiro ^a   Nishi, Jun Ichiro ^a   Nakata, Masanori ^a   Tokioka, Takeshi ^a   Nakajima, Toshihiro ^a   Kitajima, Isao ^a   Maruyama, Ikuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; LYSINE DERIVATIVE; RECOMBINANT THROMBOMODULIN; SATIGREL; THROMBIN; THROMBIN INHIBITOR; THROMBIN RECEPTOR; THROMBIN RECEPTOR ACTIVATING PEPTIDE; VALERIC ACID DERIVATIVE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN;

EID: 0032844418     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614331     Document Type: Article

References (52)

1. Berg DT, Wiley MR, Grinnell BW. Enhanced protein C activation and inhibition of fibrinogen cleavage by a thrombin modulator. Science 1996; 273: 1389-91.
2. Fenton II JW. Thrombin. Ann NY Acad Sci 1986; 485: 5-15.
3. Bouton MC, Jandrot PM, Moog S, Cazenave JP, Guillin MC, Lanza F. Thrombin interaction with a recombinant N-terminal extracellular domain of the thrombin receptor in an acellular system. Biochem J 1995; 305: 635-41.
4. Nakajima T, Kitajima I, Shin H, Takasaki I, Shigeta K, Abeyama K, Yamashita Y, Tokioka T, Soejima Y, Maruyama I. Involvement of NF-kB activation in thrombin-induced human vascular smooth muscle cell proliferation. Biochem Biophy Res Commun 1994; 204: 950-5.
5. Shin H, Nakajima T, Kitajima I, Shigeta K, Abeyama K, Imamura T, Okano T, Kawahara K, Nakamura T, Maruyama I. Thrombin receptor-mediated synovial proliferation in patients with rheumatoid arthritis. Clinical Immunol Immunopathol 1995; 76: 225-33.
6. Gurwitz D. Cunningham DD. Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc Natl Acad Sci USA 1988; 85: 3440-4.
7. Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-68.
8. Low DA, Scott RW, Baker JB, Cunningham DD. Cells regulate their mitogenic response to thrombin through release of protease nexin. Nature 1982; 298: 476-8.
9. Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, Tam T, Coughlin SR. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 1997; 386: 502-6.
10. Akiyama H, Ikeda K, Kondo H, McGeer PL. Thrombin accumulation in brains of patients with Alzheimer's disease. Neurosci Lett 1992; 146: 152-4.
11. Hoffmann MC, Nitsch C, Scotti AL, Reinhard E, Monard D. The prolonged presence of glia-derived nexin an endogenous protease inhibitor in the hippocampus after ischemia-induced delayed neuronal death. Neuroscience 1992; 49: 397-408.
12. Choi BH, Suzuki M, Kim T, Wanger SL, Cunningham DD. Protease nexin-1 localization in the human brain suggest a protective role against extravasated serine proteases. Am J Pathol 1990; 137: 741-7.
13. Kappelmayer J, Berecki D, Misz M, Olah L, Fekete I, Csiba L, Blasko G. Monocytes express tissue factor in young patients with cerebral ischemia. Cerebrovasc Dis 1998; 8: 235-9.
14. Hirashima Y, Nakamura S, Suzuki M, Kurimoto M, Endo S, Ogawa A, Takaku A. Cerebrospinal fluid tissue factor and thrombin-antithrombin III complex as indicators of tissue injury after subarchanoid hemorrhage. Stroke 1997; 28: 1666-70.
15. McKinney M. Snider RM, Richelson E. Thrombin binding to human brain and spinal cord. Mayo Clin Proc 1983; 58: 829-31.
16. Snider RM, Richelson E. Thrombin stimulation of guanosine 3',5'-monophosphate formation in murine neuroblastoma cells (clone N1E-115). Science 1983; 221: 566-8.
17. Nishino A, Suzuki M, Ohtani H, Motohashi O, Umezawa K, Nagura H, Yoshimoto T. Thrombin may contribute to the pathophysiology of central nervous system injury. J Neurotrauma 1993; 10: 167-79.
18. Vaughan PJ, Pike CJ, Cotman CW, Cunningham DD. Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J Neurosci 1995; 15: 5389-401.
19. Donovan FM, Pike CJ, Cotman CW, Cunningham DD. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci 1997; 17: 5316-26.
20. Turgeon VL, Lloyd ED, Wang S, Festoff BW, Houenou LJ, Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation. J Neurosci 1998; 18: 6882-91.
21. Smirnova IV, Zhang SX, Citron BA, Arnold PM, Festoff BW. Thrombin is an extracellular signal that activates intracellular death protease pathways inducing apoptosis in model motor neurons. J Neurobiol 1998; 36: 64-80.
22. Suidan HS, Stone SR, Hemmings BA, Monard D. Thrombin causes neurite retraction in neuronal cells through activation of cell surface receptors. Neuron 1992; 8: 363-75.
23. Beecher KL, Anderson TT, Fenton II JW, Festoff BW. Thrombin receptor peptides induce shape change in neonatal murine astrocytes in culture. J Neurosci Res 1994; 37: 108-15.
24. Weiler-Guettler H, Aird WC, Rayburn H, Husain M, Rosenberg RD. Developmentally regulated gene expression of thrombomodulin in postimplantation mouse embryos. Development 1996; 122: 2271-81.
25. Suzuki K, Kusumoto H, Deyashiki Y, Nishioka J, Maruyama I, Zushi M, Kawahara S, Honda G, Yamamoto S, Horiguchi S. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J 1987; 6: 1891-7.
26. Zushi M, Gomi K, Yamamoto S, Maruyama I, Hayashi T, Suzuki K. The last three consecutive epidermal growth factor-like structures of human thrombomodulin comprise the minimum functional domain for protein C-activating cofactor activity and anticoagulant activity. J Biol Chem 1989; 264: 10351-3.
27. Fujimori T, Harada K, Saeki T, Kogushi M, Yoshimura T, Katayama K. A new antiplatelet drug, E5510, has multiple suppressive sites during receptor-mediated signal transduction in human platelets. Jpn J Pharmacol 1991; 55: 81-91.
28. Kunimoto M. Possible involvement of the 440 kDa isoform of ankykrin B in neuritogenesis in human neuroblastoma NB-1 cells. FEBS Lett 1995; 357: 217-20.
29. Mangeney M, Schmitt JR, Leverrier Y, Thomas J, Marvel J, Brun G, Gillet G. The product of the v-src-inducible gene nr-13 is a potent anti-apoptotic factor. Oncogene 1996; 13: 1441-6.
30. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 1989; 119: 203-10.
31. Maruyama Y, Maruyama I, Soejima Y. Thrombin receptor agonist peptide decreases thrombomodulin activity in cultured human umbilical vein endothelial cells. Biochem Biophy Res Commun 1994; 199: 1262-9.
32. Troyer DA, Bouton A, Bedolla R, Padilla R. Tyrosine phosphorylation of focal adhesion kinase (pl25FAK): regulation by cAMP and thrombin in mesangial cells. J Am Soc Nephrol 1996; 7: 415-23.
33. Droogmans L, Cludts I, Cleuter Y, Kettmann R, Burny A. Nucleotide sequence of the bovine interleukin-6 gene promoter. DNA-Seq 1992; 3: 115-7.
34. Shin H, Kitajima I, Nakajima T, Shao Q, Tokioka T, Takasaki I, Hanyu N, Kubo T, Maruyam I. Thrombin receptor mediated signals induce expressions of interleukin-6 and granulocyte colony stimulating factor via NF-kB activation in synovial fibroblasts. Ann Rheum Dis 1999; 58: 55-60.
35. Blackwell TS, Holden EP, Blackwell TR, Delarco JE, Cristman JW. Cytokine-induced neutrophil chemoattractant mediates neutrophillic alveolitis in rats: association with nuclear factor kappa B activation. Am J Respir Cell Mol Biol 1994; 11: 464-72.
36. Himes SR, Coles LS, Katsikeros R, Lang RK, Shannon MF. HTLV-1 tax activation of the GM-CSF and G-CSF promoters requires the interaction of NF-kB with other transcription factor families. Oncogene 1993; 8: 3189-97.
37. Voraberger G, Schafer R, Stratowa C. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5'-regulatory region. Induction by cytokines and phorbol ester. J Immunol 1991; 147: 2777-86.
38. Sugama Y, Tiruppathi C, Janakidevi K, Anderson TT, Fenton JW II, Malik AB. Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion. J Cell Biol 1992; 119: 935-44.
39. Zimmermann T, Bierhaus A, Nagel M, Albrecht S, Saeger HD. NF-kB activation-a central mediator of sepsis. Langenbechs Arch-Chir-Suppl-Kongressbd 1997; 114: 363-7.
40. Maruyama I, Majerus PW. The turnover of thrombin-thrombomodulin complex in cultured human umbilical vein endothelial cells and A549 lung cancer cells. Endocytosis and degradation of thrombin. J Biol Chem 1985; 260: 15432-8.
41. Tsiang M, Lentz SR, Dittman WA, Wen D, Scarpati EM, Sadler JE. Equilibrium binding of thrombin to recombinant human thrombomodulin: effect of hirudin, fibrinogen, factor Va, and peptide analogues. Biochemistry 1990; 29: 10602-12.
42. Nakajima T, Kitajima I, Shin H, Matsumoto W, Soejima Y, Maruyama I. E5510 antagonizes thrombin receptor signals by inhibiting NF-kB activation. Biochem Biophys Res Commun 1994; 203: 1184-7.
43. Kahn ML, Zheng YW, Huang W, Bigornia V. Zeng D, Moff S, Farese RV Jr. Tam C, Coughlin SR. A dual thrombin receptor system for platelet activation. Nature 1998, 394: 690-4.
44. Valle A, Kinet JP. N-acetyl cysteine inhibits antigen-mediated Syk, but not Lyn tyrosine kinase activation in mast cells. FEBS Lett 1995; 357: 41-4.
45. Rezaul K, Sada K, Yamamura H. Involvement of reactive oxygen intermediates in lectin-induced protein-tyrosine phosphorylation of Syk in THP-1 cells. Biochem Biophys Res Commun 1998; 246: 863-7.
46. Chen YC, Lin-Shiau SY, Lin JK. Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J Cell Physiol 1998; 177:324-33.
47. Simizu S, Takada M, Omezawa K, Imoto M. Requirement of caspase-3 (-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs. J Biol Chem 1998; 273: 26900-7.
48. Simizu S, Omezawa K, Takada M, Arber N, Imoto M. Induction of hydrogen peroxide production and Bax expression by caspase-3 (-like) proteases in tyrosine kinase inhibitor-induced apoptosis in human small cell lung carcinoma cells. Exp Cell Res 1998; 238: 197-203.
49. Behl C. Skutella T. Lezoualach F, Post A, Widmann M, Newton CJ, Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 1997; 51: 535-41.
50. Leoncini G, Signorello MG, Piana A, Carrubba M, Armani U. Hyperactivity and increased hydrogen peroxide formation in platelets of NIDDM patients. Thromb Res 1997; 86: 153-60.
51. Heye N, Cervos NJ. Microthromboemboli in acute infarcts: analysis of 40 autopsy cases. Stroke 1996; 27: 431-4.
52. Walz DA, Anderson GF, Ciaglowski RE, Aiken M, Fenton JW II. Thrombin-elicited contractile responses of aortic smooth muscle. Proc Soc Exp Biol Med 1985; 180: 518-26.